Birchview Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
4,250
-3,250
| -43% | -$934K | 1.21% | 24 |
|
|
2025
Q1 | $2.31M | Sell |
7,500
-2,500
| -25% | -$771K | 2.01% | 13 |
|
|
2024
Q4 | $3.53M | Hold |
10,000
| – | – | 2.87% | 8 |
|
|
2024
Q3 | $3.58M | Hold |
10,000
| – | – | 3.1% | 5 |
|
|
2024
Q2 | $3.19M | Sell |
10,000
-1,000
| -9% | -$319K | 2.94% | 9 |
|
|
2024
Q1 | $2.53M | Hold |
11,000
| – | – | 2.06% | 12 |
|
|
2023
Q4 | $2.42M | Hold |
11,000
| – | – | 1.89% | 11 |
|
|
2023
Q3 | $2.48M | Sell |
11,000
-4,000
| -27% | -$903K | 2.11% | 9 |
|
|
2023
Q2 | $3.31M | Hold |
15,000
| – | – | 2.48% | 9 |
|
|
2023
Q1 | $3.36M | Hold |
15,000
| – | – | 2.63% | 8 |
|
|
2022
Q4 | $4.17M | Hold |
15,000
| – | – | 2.95% | 8 |
|
|
2022
Q3 | $3.14M | Hold |
15,000
| – | – | 2.21% | 9 |
|
|
2022
Q2 | $3.54M | Sell |
15,000
-3,000
| -17% | -$707K | 2.57% | 7 |
|
|
2022
Q1 | $3.23M | Hold |
18,000
| – | – | 2.32% | 9 |
|
|
2021
Q4 | $3.89M | Hold |
18,000
| – | – | 2.51% | 9 |
|
|
2021
Q3 | $3.32M | Hold |
18,000
| – | – | 2.26% | 9 |
|
|
2021
Q2 | $3.23M | Hold |
18,000
| – | – | 1.93% | 10 |
|
|
2021
Q1 | $3.01M | Hold |
18,000
| – | – | 1.79% | 10 |
|
|
2020
Q4 | $2.73M | Hold |
18,000
| – | – | 1.57% | 13 |
|
|
2020
Q3 | $1.82M | Hold |
18,000
| – | – | 1.21% | 16 |
|
|
2020
Q2 | $2.18M | Hold |
18,000
| – | – | 1.32% | 12 |
|
|
2020
Q1 | $1.71M | Buy |
18,000
+13,000
| +260% | +$1.23M | 1.51% | 10 |
|
|
2019
Q4 | $440K | Buy |
+5,000
| New | +$440K | 0.32% | 36 |
|